KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Other Non Operating Income (2016 - 2025)

Edwards Lifesciences (EW) has 9 years of Other Non Operating Income data on record, last reported at $3.2 million in Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 90.39% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $7.2 million, down 89.55%, while the annual FY2025 figure was $7.2 million, 89.55% down from the prior year.
  • Other Non Operating Income reached $3.2 million in Q4 2025 per EW's latest filing, up from $2.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $33.3 million in Q4 2024 and bottomed at -$1.3 million in Q2 2025.
  • Average Other Non Operating Income over 4 years is $6.9 million, with a median of $2.9 million recorded in 2025.
  • Peak YoY movement for Other Non Operating Income: soared 674.42% in 2024, then tumbled 165.0% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $1.4 million in 2021, then soared by 207.14% to $4.3 million in 2023, then skyrocketed by 674.42% to $33.3 million in 2024, then tumbled by 90.39% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $3.2 million in Q4 2025, $2.7 million in Q3 2025, and -$1.3 million in Q2 2025.